603669 灵康药业
已收盘 12-12 15:00:00
资讯
新帖
简况
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,12月02日股价下跌0.96%
证券之星 · 12-02
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,12月02日股价下跌0.96%
灵康药业(603669)披露可转换公司债券付息公告,11月24日股价上涨1.76%
证券之星 · 11-24
灵康药业(603669)披露可转换公司债券付息公告,11月24日股价上涨1.76%
每周股票复盘:灵康药业(603669)控股股东新增质押5400万股
证券之星 · 11-16
每周股票复盘:灵康药业(603669)控股股东新增质押5400万股
灵康药业(603669)股东灵康控股集团有限公司质押5400万股,占总股本7.49%
证券之星 · 11-14
灵康药业(603669)股东灵康控股集团有限公司质押5400万股,占总股本7.49%
每周股票复盘:灵康药业(603669)股东户数增32.6%,灵康转债或触向下修正
证券之星 · 11-02
每周股票复盘:灵康药业(603669)股东户数增32.6%,灵康转债或触向下修正
灵康药业(603669)2025年三季报简析:营收上升亏损收窄,盈利能力上升
证券之星 · 11-01
灵康药业(603669)2025年三季报简析:营收上升亏损收窄,盈利能力上升
图解灵康药业三季报:第三季度单季净利润同比增长118.96%
证券之星 · 10-30
图解灵康药业三季报:第三季度单季净利润同比增长118.96%
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,10月29日股价下跌0.9%
证券之星 · 10-29
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,10月29日股价下跌0.9%
灵康药业最新公告:子公司灵康制药产品注射用头孢唑肟钠拟中选全国药品集中采购
证券之星 · 10-29
灵康药业最新公告:子公司灵康制药产品注射用头孢唑肟钠拟中选全国药品集中采购
每周股票复盘:灵康药业(603669)完成董事会换届及章程修订
证券之星 · 10-12
每周股票复盘:灵康药业(603669)完成董事会换届及章程修订
每周股票复盘:灵康药业(603669)拟取消监事会并修订章程
证券之星 · 09-28
每周股票复盘:灵康药业(603669)拟取消监事会并修订章程
灵康药业(603669)披露拟变更注册资本及董事会换届选举议案,9月22日股价下跌0.86%
证券之星 · 09-22
灵康药业(603669)披露拟变更注册资本及董事会换届选举议案,9月22日股价下跌0.86%
每周股票复盘:灵康药业(603669)因涨幅偏离值登龙虎榜
证券之星 · 08-31
每周股票复盘:灵康药业(603669)因涨幅偏离值登龙虎榜
灵康药业股价微涨0.48% 化学制药企业成交额突破4亿元
金融界 · 08-27
灵康药业股价微涨0.48% 化学制药企业成交额突破4亿元
8月25日灵康药业(603669)龙虎榜数据
证券之星 · 08-25
8月25日灵康药业(603669)龙虎榜数据
异动快报:灵康药业(603669)8月25日9点38分触及涨停板
证券之星 · 08-25
异动快报:灵康药业(603669)8月25日9点38分触及涨停板
灵康药业(603669)2025年中报简析:营收上升亏损收窄
证券之星 · 08-24
灵康药业(603669)2025年中报简析:营收上升亏损收窄
图解灵康药业中报:第二季度单季净利润同比增长29.75%
证券之星 · 08-22
图解灵康药业中报:第二季度单季净利润同比增长29.75%
灵康药业涨5.19% 医药流通业务提振股价
智选洞察 · 08-11
灵康药业涨5.19% 医药流通业务提振股价
化学制剂上市公司董秘PK:40岁及以下的董秘占比33% 莎普爱思黄明雄为最年轻男董秘
新浪证券 · 08-08
化学制剂上市公司董秘PK:40岁及以下的董秘占比33% 莎普爱思黄明雄为最年轻男董秘
加载更多
公司概况
公司名称:
灵康药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-28
主营业务:
灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品有注射用石杉碱甲,注射用维库溴铵,注射用拉氧头孢钠,注射用头孢呋辛钠,注射用头孢美唑钠,注射用氟马西尼,盐酸多巴胺注射液,盐酸艾司洛尔注射液,注射用头孢唑肟钠,注射用氨曲南,丙氨酰谷氨酰胺注射液,左卡尼汀注射液。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉,灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。
发行价格:
11.70
{"stockData":{"symbol":"603669","market":"SH","secType":"STK","nameCN":"灵康药业","latestPrice":4.67,"timestamp":1765522800000,"preClose":4.71,"halted":0,"volume":8759903,"delay":0,"changeRate":-0.0085,"floatShares":721000000,"shares":721000000,"eps":-0.1642,"marketStatus":"已收盘","change":-0.04,"latestTime":"12-12 15:00:00","open":4.69,"high":4.77,"low":4.66,"amount":41239600,"amplitude":0.0234,"askPrice":4.68,"askSize":269,"bidPrice":4.67,"bidSize":336,"shortable":0,"etf":0,"ttmEps":-0.1642,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":4.71,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":5.18,"lowLimit":4.24,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":721245983,"isCdr":false,"pbRate":4.99,"roa":"--","roe":"--","epsLYR":-0.18,"committee":-0.23199,"marketValue":3368000000,"turnoverRate":0.0121,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-12-15。","floatMarketCap":3368000000},"requestUrl":"/m/hq/s/603669","defaultTab":"news","newsList":[{"id":"2588039447","title":"灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,12月02日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588039447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588039447?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:53","pubTimestamp":1764669199,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘,灵康药业报收于5.17元,较前一交易日下跌0.96%,最新总市值为37.29亿元。该股当日开盘5.21元,最高5.21元,最低5.11元,成交额达2733.39万元,换手率为0.74%。近日,灵康药业集团股份有限公司发布关于“灵康转债”预计满足转股价格修正条件的提示性公告。若在任意连续三十个交易日内有至少十五个交易日收盘价低于该阈值,将触发修正条件。公司将在触发当日召开董事会审议是否修正转股价格,并及时披露相关信息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200027041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","603669","BK0033"],"gpt_icon":0},{"id":"2585049883","title":"灵康药业(603669)披露可转换公司债券付息公告,11月24日股价上涨1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585049883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585049883?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:20","pubTimestamp":1763994019,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘,灵康药业报收于5.2元,较前一交易日上涨1.76%,最新总市值为37.5亿元。该股当日开盘5.13元,最高5.24元,最低5.13元,成交额达3983.33万元,换手率为1.07%。近日,灵康药业集团股份有限公司发布可转换公司债券付息公告,灵康转债将于2025年12月1日支付第五年利息,计息期间为2024年12月1日至2025年11月30日,票面利率2.50%,每张兑息2.50元(含税)。付息债权登记日为2025年11月28日,除息日和兑息发放日均为2025年12月1日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","603669","BK0033"],"gpt_icon":0},{"id":"2583042659","title":"每周股票复盘:灵康药业(603669)控股股东新增质押5400万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583042659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583042659?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:00","pubTimestamp":1763233238,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,灵康药业报收于5.75元,较上周的5.63元上涨2.13%。本周,灵康药业11月11日盘中最高价报6.05元。11月10日盘中最低价报5.58元。灵康药业当前最新总市值41.47亿元,在化学制药板块市值排名122/151,在两市A股市值排名3887/5165。本次质押后,灵康控股累计质押股份数量为10,365.96万股,占其持股总数的30.52%,占公司总股本的14.37%。灵康控股资信状况良好,质押风险可控,不会导致公司实际控制权变更,亦不会对公司治理及持续经营产生影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","603669","BK0033"],"gpt_icon":0},{"id":"2583572263","title":"灵康药业(603669)股东灵康控股集团有限公司质押5400万股,占总股本7.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583572263","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583572263?lang=zh_cn&edition=full","pubTime":"2025-11-14 18:34","pubTimestamp":1763116474,"startTime":"0","endTime":"0","summary":"证券之星消息,灵康药业11月14日公开信息显示,股东灵康控股集团有限公司向中国工商银行股份有限公司杭州湖墅支行合计质押5400.0万股,占总股本7.49%。质押详情见下表:截止本公告日,股东灵康控股集团有限公司已累计质押股份1.04亿股,占其持股总数的30.52%。灵康药业主营业务:化药处方药的研发、生产和销售.。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400033004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0056","BK0033"],"gpt_icon":0},{"id":"2580472404","title":"每周股票复盘:灵康药业(603669)股东户数增32.6%,灵康转债或触向下修正","url":"https://stock-news.laohu8.com/highlight/detail?id=2580472404","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580472404?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:54","pubTimestamp":1762037654,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,灵康药业报收于5.62元,较上周的5.56元上涨1.08%。本周,灵康药业10月27日盘中最高价报5.64元。股本股东变化股东户数变动截至2025年9月30日,灵康药业股东户数为2.52万户,较6月30日增加6199.0户,增幅32.6%。公司公告汇总关于“灵康转债”预计满足转股价格修正条件的提示性公告证券代码:603669,证券简称:灵康药业;债券代码:113610,债券简称:灵康转债。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0056","BK0033"],"gpt_icon":0},{"id":"2580412143","title":"灵康药业(603669)2025年三季报简析:营收上升亏损收窄,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2580412143","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580412143?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:27","pubTimestamp":1761949659,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期灵康药业发布2025年三季报。截至本报告期末,公司营业总收入2.82亿元,同比上升22.0%,归母净利润-3450.31万元,同比上升26.42%。按单季度数据看,第三季度营业总收入1.1亿元,同比上升23.12%,第三季度归母净利润123.05万元,同比上升118.96%。本报告期灵康药业盈利能力上升,毛利率同比增幅2.01%,净利率同比增幅39.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100006166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"gpt_icon":0},{"id":"2579146172","title":"图解灵康药业三季报:第三季度单季净利润同比增长118.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579146172","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579146172?lang=zh_cn&edition=full","pubTime":"2025-10-30 20:01","pubTimestamp":1761825692,"startTime":"0","endTime":"0","summary":"证券之星消息,灵康药业2025年三季报显示,前三季度公司主营收入2.82亿元,同比上升22.0%;归母净利润-3450.31万元,同比上升26.42%;扣非净利润-5645.4万元,同比上升37.87%;其中2025年第三季度,公司单季度主营收入1.1亿元,同比上升23.12%;单季度归母净利润123.05万元,同比上升118.96%;单季度扣非净利润-1090.91万元,同比上升70.07%;负债率38.79%,投资收益-330.4万元,财务费用1526.76万元,毛利率43.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000040534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"gpt_icon":0},{"id":"2579033975","title":"灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,10月29日股价下跌0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579033975","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579033975?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:13","pubTimestamp":1761732825,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘,灵康药业报收于5.51元,较前一交易日下跌0.9%,最新总市值为39.74亿元。该股当日开盘5.59元,最高5.59元,最低5.4元,成交额达4763.89万元,换手率为1.2%。公司近日发布关于“灵康转债”预计满足转股价格修正条件的提示性公告。公告显示,证券代码为603669,证券简称灵康药业;债券代码为113610,债券简称灵康转债。公司将按规定在触发条件当日召开董事会审议是否修正转股价格,并及时披露相关信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900038617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","603669","BK0239"],"gpt_icon":0},{"id":"2579922069","title":"灵康药业最新公告:子公司灵康制药产品注射用头孢唑肟钠拟中选全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2579922069","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579922069?lang=zh_cn&edition=full","pubTime":"2025-10-29 16:48","pubTimestamp":1761727701,"startTime":"0","endTime":"0","summary":"灵康药业(603669.SH)公告称,公司全资子公司灵康制药参加了国家组织药品联合采购办公室组织的第十一批全国药品集中采购工作,其产品注射用头孢唑肟钠拟中选。该产品2024年销售额为2300.89万元,占公司2024年度营业收入的6.06%。若中选后签订购销合同并实施,将促进公司相关产品市场开拓及提升品牌影响力,对未来业绩产生积极影响。但目前合同签订等后续事项存在不确定性,公司将密切关注进展并履行信息披露义务。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900033932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK1191","BK0056","BK1574","603669","01477"],"gpt_icon":0},{"id":"2574450704","title":"每周股票复盘:灵康药业(603669)完成董事会换届及章程修订","url":"https://stock-news.laohu8.com/highlight/detail?id=2574450704","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574450704?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:50","pubTimestamp":1760208623,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,灵康药业报收于5.39元,较上周的5.47元下跌1.46%。本周,灵康药业10月9日盘中最高价报5.51元。上述人员任期均与第五届董事会任期一致。灵康药业集团股份有限公司于2025年10月10日召开2025年第二次临时股东大会,会议由董事会召集,董事长陶灵萍主持,表决方式符合相关法律法规及公司章程。出席会议的股东共132人,代表有表决权股份总数的43.9888%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","603669"],"gpt_icon":0},{"id":"2570289162","title":"每周股票复盘:灵康药业(603669)拟取消监事会并修订章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2570289162","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570289162?lang=zh_cn&edition=full","pubTime":"2025-09-28 02:55","pubTimestamp":1758999310,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘,灵康药业报收于5.62元,较上周的5.8元下跌3.1%。本周关注点公司公告汇总:灵康药业拟取消监事会,其职权由董事会审计委员会行使。会议将审议《关于变更注册资本、取消监事会并修订公司章程的议案》《关于修订公司部分治理制度的议案》及下属子议案,并采用累积投票方式选举第五届董事会非独立董事和独立董事。所有候选人已通过董事会提名委员会资格审查。细则自董事会审议通过之日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","603669","BK0239","BK0033"],"gpt_icon":0},{"id":"2569464733","title":"灵康药业(603669)披露拟变更注册资本及董事会换届选举议案,9月22日股价下跌0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569464733","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569464733?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:46","pubTimestamp":1758552400,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘,灵康药业报收于5.75元,较前一交易日下跌0.86%,最新总市值为41.47亿元。该股当日开盘5.8元,最高5.8元,最低5.69元,成交额达5978.16万元,换手率为1.44%。股权登记日为2025年9月26日。股东可于2025年10月9日前办理参会登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200034979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0056","BK0033","BK0239"],"gpt_icon":0},{"id":"2563383637","title":"每周股票复盘:灵康药业(603669)因涨幅偏离值登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2563383637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563383637?lang=zh_cn&edition=full","pubTime":"2025-08-31 10:02","pubTimestamp":1756605739,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘,灵康药业报收于6.2元,较上周的5.69元上涨8.96%。本周,灵康药业8月27日盘中最高价报6.62元。8月25日盘中最低价报5.73元。本周共计1次涨停收盘,无跌停收盘情况。灵康药业当前最新总市值44.72亿元,在化学制药板块市值排名115/150,在两市A股市值排名3589/5152。本周关注点交易信息汇总:灵康药业因日收盘价格涨幅偏离值达7%登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100002997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","603669"],"gpt_icon":0},{"id":"2562029753","title":"灵康药业股价微涨0.48% 化学制药企业成交额突破4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562029753","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562029753?lang=zh_cn&edition=full","pubTime":"2025-08-27 00:20","pubTimestamp":1756225235,"startTime":"0","endTime":"0","summary":"灵康药业最新股价报6.29元,较前一交易日上涨0.03元。盘中最高触及6.43元,最低下探至6.21元,全天成交670976手,成交金额达4.22亿元。该公司属于化学制药行业,注册地位于西藏自治区。主要经营范围包括药品生产、销售等业务。企业总市值45.37亿元,流通市值与总市值相同。8月26日早盘时段,该股曾出现快速回调走势,五分钟内跌幅超过2%,当时成交金额达1.02亿元。当日主力资金净流出3729.9万元,占流通市值比例0.82%。近五个交易日主力资金整体呈现净流入状态,累计净流入1819.62万元。风险提示:股市有风险,投资需谨慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/27002052718346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["603669","BK1191","BK0056","BK0033","BK1574","BK0239","01477"],"gpt_icon":0},{"id":"2562217986","title":"8月25日灵康药业(603669)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2562217986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562217986?lang=zh_cn&edition=full","pubTime":"2025-08-25 17:29","pubTimestamp":1756114182,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年8月25日公布的交易公开信息显示,灵康药业因有价格涨跌幅限制的日收盘价格涨幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年8月25日收盘,灵康药业报收于6.26元,上涨10.02%,涨停,换手率3.91%,成交量28.18万手,成交额1.72亿元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500024116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","603669","BK0033"],"gpt_icon":0},{"id":"2562962452","title":"异动快报:灵康药业(603669)8月25日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2562962452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562962452?lang=zh_cn&edition=full","pubTime":"2025-08-25 09:41","pubTimestamp":1756086083,"startTime":"0","endTime":"0","summary":"证券之星8月25日盘中消息,9点38分灵康药业触及涨停板。目前价格6.26,上涨10.02%。其所属行业化学制药目前上涨。领涨股为苑东生物。该股为西藏概念,民营医院,流感概念热股,当日西藏概念概念上涨0.48%,民营医院概念上涨0.31%,流感概念上涨0.19%。8月22日的资金流向数据方面,主力资金净流出433.57万元,占总成交额5.31%,游资资金净流入306.81万元,占总成交额3.76%,散户资金净流入126.76万元,占总成交额1.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500004127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0033","BK0056"],"gpt_icon":0},{"id":"2561253647","title":"灵康药业(603669)2025年中报简析:营收上升亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2561253647","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561253647?lang=zh_cn&edition=full","pubTime":"2025-08-24 06:06","pubTimestamp":1755986806,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期灵康药业发布2025年中报。根据财报显示,灵康药业营收上升亏损收窄。截至本报告期末,公司营业总收入1.72亿元,同比上升21.3%,归母净利润-3573.37万元,同比上升11.55%。筹资活动产生的现金流量净额变动幅度为102.22%,原因:本期偿还借款减少。证券之星价投圈财报分析工具显示:业务评价:去年的净利率为-34.43%,算上全部成本后,公司产品或服务的附加值不高。),公司上市来已有年报9份,亏损年份3次,显示生意模式比较脆弱。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400001285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"gpt_icon":0},{"id":"2561473543","title":"图解灵康药业中报:第二季度单季净利润同比增长29.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561473543","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561473543?lang=zh_cn&edition=full","pubTime":"2025-08-22 18:18","pubTimestamp":1755857909,"startTime":"0","endTime":"0","summary":"证券之星消息,灵康药业2025年中报显示,公司主营收入1.72亿元,同比上升21.3%;归母净利润-3573.37万元,同比上升11.55%;扣非净利润-4554.49万元,同比上升16.31%;其中2025年第二季度,公司单季度主营收入1.21亿元,同比上升88.01%;单季度归母净利润-1711.24万元,同比上升29.75%;单季度扣非净利润-2763.0万元,同比上升18.73%;负债率39.34%,投资收益-304.65万元,财务费用1012.43万元,毛利率17.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200034373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"gpt_icon":0},{"id":"2558868634","title":"灵康药业涨5.19% 医药流通业务提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2558868634","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558868634?lang=zh_cn&edition=full","pubTime":"2025-08-11 14:20","pubTimestamp":1754893207,"startTime":"0","endTime":"0","summary":"灵康药业股价大幅上涨,最新价5.67元,上涨5.19%。资金博弈与技术面共振灵康药业8月11日盘中最高触及5.68元,单日振幅达5.94%,成交额突破1.2亿元。截至8月11日,主力资金当日净流入350.57万元,但近5个交易日累计仍呈净流出状态。叠加8月1日龙虎榜机构席位单日抛售超1700万元,市场对转股价修正议案带来的股权稀释预期产生分歧。尽管医药流通业务收入占比提升至12.19%,但2025年一季度营收同比下滑34.79%,经营性现金流仍未转正。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811142008a6df00cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811142008a6df00cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","603669","159938","BK0239","BK0056"],"gpt_icon":0},{"id":"2557251954","title":"化学制剂上市公司董秘PK:40岁及以下的董秘占比33% 莎普爱思黄明雄为最年轻男董秘","url":"https://stock-news.laohu8.com/highlight/detail?id=2557251954","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557251954?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:47","pubTimestamp":1754621220,"startTime":"0","endTime":"0","summary":"新浪财经《2024年度A股董秘数据报告》显示,2024年A股上市公司董秘薪酬合计达40.86亿元,平均年薪75.43万元。从董秘的年龄分布来看,40岁-50岁董秘是市场的中坚力量,占比共计达到46%;50岁以上的董秘占比为21%;小于或等于40岁的董秘群体占比为33%。其中,目前仍任职的最年轻的男上市公司董秘年龄31岁,为莎普爱思的黄明雄;最年轻的女董秘年龄为33岁,为百利天恒的陈英格。从薪酬分布看,A股化学制剂上市公司董秘年薪平均值为91.48万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808104748a47c2a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808104748a47c2a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","603669","BK0012","BK0028","BK0070","BK0188","BK0185","600267","688382","688506","688192","BK0239","BK0096","603168","688373"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765564480708,"stockEarnings":[{"period":"1week","weight":-0.0789},{"period":"1month","weight":-0.1892},{"period":"3month","weight":-0.2217},{"period":"6month","weight":-0.095},{"period":"1year","weight":-0.4551},{"period":"ytd","weight":-0.1105}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"灵康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25212人(较上一季度增加32.60%)","perCapita":"28607股","listingDate":"2015-05-28","address":"西藏自治区山南市乃东区国道349号(结巴乡段)20号","registeredCapital":"72124万元","survey":" 灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品有注射用石杉碱甲,注射用维库溴铵,注射用拉氧头孢钠,注射用头孢呋辛钠,注射用头孢美唑钠,注射用氟马西尼,盐酸多巴胺注射液,盐酸艾司洛尔注射液,注射用头孢唑肟钠,注射用氨曲南,丙氨酰谷氨酰胺注射液,左卡尼汀注射液。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉,灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。","listedPrice":11.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"灵康药业,603669,灵康药业股票,灵康药业股票老虎,灵康药业股票老虎国际,灵康药业行情,灵康药业股票行情,灵康药业股价,灵康药业股市,灵康药业股票价格,灵康药业股票交易,灵康药业股票购买,灵康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}